TRYNGOLZA (AUTOINJECTOR)

Growth

olezarsen sodium

Ionis Pharmaceuticals
NDASUBCUTANEOUSSOLUTIONPriority Review
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 1, 2034
99 months away
Patent Expiry
May 1, 2034
Exclusivity Expiry
Dec 19, 2031

Patent Records (5)

Patent #ExpiryTypeUse Code
9157082
Apr 27, 2032
U-4050
9593333
Feb 14, 2034
U-4050
12509684
May 1, 2034
U-4050
9127276
May 1, 2034
Substance
—
9163239
May 1, 2034
Substance
—
Company
Ionis Pharmaceuticals
Ionis Pharmaceuticals
CARLSBAD, CA
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers